Recent evidence indicates that the LPA2 receptor can also mediate profibrotic effects of LPA, such as activation of latent transforming growth factor-β (TGF-β), and genetic deficiency of this receptor also results in protection against the development of lung fibrosis in mice [13,20,21]. This evidence concerns the gene LPA and pulmonary fibrosis.